Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Procalcitonin-Guided Antimicrobial Therapy—All About the Algorithm—Reply

Procalcitonin-Guided Antimicrobial Therapy—All About the Algorithm—Reply Letters Funding/Support: This project was not supported by any external grants or sicians refrained from stopping antibiotics in high-risk funds. Mr Gupta is supported by the Yale University School of Medicine Office of patients, such as patients with septic shock. In the SAPS Student Research. Dr Kesselheim is supported by the Laura and John Arnold trial, we compared the characteristics of the patients evalu- Foundation and the Harvard Program in Therapeutic Science. ated with the algorithm vs those who were not. The percent- Role of the Funder/Sponsor: The funders/sponsors had no role in the design age of septic shock was the same in both groups and Acute and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to Physiology and Chronic Health Evaluation IV and SOFA submit the manuscript for publication. scores at inclusion were lower in those who were not evalu- Additional Contributions: The authors would like to acknowledge the ated by the algorithm. It seems physicians do not want to contributions of Jeremy Greene, MD, PhD, of the Johns Hopkins University rely completely on PCT levels. We understand that the high School of Medicine, Baltimore, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Procalcitonin-Guided Antimicrobial Therapy—All About the Algorithm—Reply

Reinhart, Konrad; Bloos, Frank
JAMA Internal Medicine , Volume 177 (1) – Jan 1, 2017
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/procalcitonin-guided-antimicrobial-therapy-all-about-the-algorithm-D63qin0IRu

References (4)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2016.7820
pmid
28030737
Publisher site
See Article on Publisher Site

Abstract

Letters Funding/Support: This project was not supported by any external grants or sicians refrained from stopping antibiotics in high-risk funds. Mr Gupta is supported by the Yale University School of Medicine Office of patients, such as patients with septic shock. In the SAPS Student Research. Dr Kesselheim is supported by the Laura and John Arnold trial, we compared the characteristics of the patients evalu- Foundation and the Harvard Program in Therapeutic Science. ated with the algorithm vs those who were not. The percent- Role of the Funder/Sponsor: The funders/sponsors had no role in the design age of septic shock was the same in both groups and Acute and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to Physiology and Chronic Health Evaluation IV and SOFA submit the manuscript for publication. scores at inclusion were lower in those who were not evalu- Additional Contributions: The authors would like to acknowledge the ated by the algorithm. It seems physicians do not want to contributions of Jeremy Greene, MD, PhD, of the Johns Hopkins University rely completely on PCT levels. We understand that the high School of Medicine, Baltimore,

Journal

JAMA Internal Medicine – American Medical Association

Published: Jan 1, 2017

There are no references for this article.